FRANKLIN LAKES, N.J., Oct. 11, 2022 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today was named to Forbes' 2022 list of the World's Best Employers.
"Empowering our teams to excel in their careers has been a longstanding priority at BD, and this award is a testament to the commitment we make to our 75,000 employees to be an employer of choice where they can thrive professionally while doing incredibly meaningful work for patients and customers," said Shana Neal, executive vice president and chief people officer at BD. "We have the most talented team in health care, and we believe the type of work we do, combined with our continued focus on servant leadership, development opportunities, employee well-being, and inclusion, diversity and equity differentiates us as a great place to work."
The ranking is based on an independent survey of more than 150,000 workers from 57 countries. Participants rated their willingness to recommend their own employers to friends and family, in addition to evaluating other employers in their respective industries in areas including image, economic footprint, talent development, gender equality and social responsibility.
This year, BD also ranked first in the health care equipment and services industry in Forbes' America's Best Large Employers List and was included in the publication's list of Best Employers for Diversity, among numerous other accolades.
This recognition demonstrates BD's ongoing progress in advancing its environmental, social and governance (ESG) strategy, and efforts to achieve its 2030+ goals for promoting a healthy workforce and communities. BD's focus areas include a healthy and thriving workforce that cultivates the company's culture of inclusion, safety and well-being, which also contributes to community health and company health.
About BD
BD is one of the largest global medical technology companies in the world and is advancing the world of health by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its 75,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit bd.com or connect with us on LinkedIn at www.linkedin.com/company/bd1/ and Twitter @BDandCo.
Contacts: |
|
Media: |
Investors: |
Troy Kirkpatrick |
Francesca DeMartino |
VP, Public Relations |
SVP, Head of Investor Relations |
858.617.2361 |
201.847.5743 |
SOURCE BD (Becton, Dickinson and Company)
![](https://rt.prnewswire.com/rt.gif?NewsItemId=NY99187&Transmission_Id=202210111352PR_NEWS_USPR_____NY99187&DateId=20221011)
Share this article